We are proud to announce that CheckEye has been selected as one of the 10 high-potential startups to join the prestigious EBRD Star Venture Programme. This 18-month program, funded by the Swiss Agency for Development and Cooperation, is designed to support innovative Ukrainian startups, helping them scale internationally and achieve global success.
At CheckEye, we are committed to transforming healthcare with our AI-powered platform for mass screening of chronic diseases. By leveraging artificial intelligence, we aim to provide early detection and preventative healthcare solutions, improving lives across the globe.
Through the EBRD Star Venture Programme, CheckEye will receive tailored business diagnostics, mentorship from global experts, and access to international markets and investors. This is a significant opportunity to further develop our platform and expand our reach, ultimately empowering healthcare providers and patients to make more informed decisions about chronic disease management.
This recognition highlights our goal of creating a future where disease prevention becomes the standard and access to quality healthcare is available to everyone. We are grateful to the EBRD and the Swiss Agency for Development and Cooperation for their support of innovative Ukrainian startups and their role in driving positive change in the global healthcare sector.
To learn more about the EBRD Star Venture Programme, visit: EBRD Star Venture Programme.